Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

Clinical trial NCT01457495 · COMPLETED

Trial details

NCT number: NCT01457495
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B Diphtheria Haemophilus Influenzae Type b (Hib)Poliomyelitis Pertussis Tetanus

Start date: 1998-09-01
Primary completion: 1999-09-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.